The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. MBX Biosciences Inc shares valued at $272,790 were purchased by Hawryluk P. Kent on Oct 20 ’25. At $13.64 per share, Hawryluk P. Kent acquired 20,000 shares. The insider’s holdings grew to 468,277 shares worth approximately $14.77 million following the completion of this transaction.
Also, Hoerter Steven L. purchased 20,000 shares, netting a total of over 264,984 in proceeds. Following the buying of shares at $13.25 each, the insider now holds 20,000 shares.
Before that, Heron Patrick J had added 666,666 shares to its account. In a trade valued at $11,999,988, the Director bought MBX Biosciences Inc shares for $18.00 each. Upon closing the transaction, the insider’s holdings increased to 666,666 shares, worth approximately $164.62 million.
As published in their initiating research note from Goldman on December 04, 2025, MBX Biosciences Inc [MBX] has been a Sell and the price target has been revised to $18. Analysts at TD Cowen started covering the stock with ‘”a Buy”‘ outlook in a report released in early November. As of October 15, 2025, Truist has initiated its “Buy” rating for MBX.
Analyzing MBX Stock Performance
On last trading session, MBX Biosciences Inc [NASDAQ: MBX] rose 2.07% to $31.54. The stock’s lowest price that day was $30.725, but it reached a high of $32.05 in the same session. During the last five days, there has been a drop of approximately -2.05%. Over the course of the year, MBX Biosciences Inc shares have jumped approximately 57.15%. Shares of the company reached a 52-week high of $35.55 on 12/22/25 and a 52-week low of $4.81 on 04/07/25.
Support And Resistance Levels for MBX Biosciences Inc (MBX)
According to the 24-hour chart, there is a support level at 30.83, which, if violated, would cause prices to drop to 30.11. In the upper region, resistance lies at 32.15. The next price resistance is at 32.76. RSI (Relative Strength Index) is 56.48 on the 14-day chart, showing neutral technical sentiment.
Is MBX Biosciences Inc subject to short interest?
Stocks of MBX Biosciences Inc saw a sharp steep in short interest on 2025-12-15 dropping by -1.02 million shares to 3.61 million. Data from Yahoo Finance shows that the short interest on 2025-11-14 was 4.63 million shares. A decline of -28.17% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.86 of the overall float, the days-to-cover ratio (short ratio) decline to 4.86.
Which companies own the most shares of MBX Biosciences Inc (MBX)?
In terms of MBX Biosciences Inc share price expectations, FactSet research, analysts set an average price target of 38 in the next 12 months, up nearly 22.98% from the previous closing price of $30.9. Analysts anticipate MBX Biosciences Inc stock to reach 50 by 2026, with the lowest price target being 18. On August 05, 2025, Mizuho assigned a price target of “an Outperform” to the stock and initiated coverage with a $38.
